Persistence of Gastric Atrophy and Intestinal Metaplasia Six Months After H. pylori Treatment: A Retrospective Cohort Study
Open Access
- 30 September 2026
- journal article
- Published by Sağlık Bilimleri Üniversitesi, Bursa Tıp Fakültesi in Journal of Bursa Faculty of Medicine
- Vol. 4 (3) , 58-62
Abstract
Objective: To assess the persistence and regression of gastric atrophy and intestinal metaplasia (IM) approximately six months after Helicobacter pylori treatment in patients undergoing repeat gastric biopsy.Methods: This single-center retrospective cohort included 70 patients with biopsy-confirmed H. pylori infection who received 14-day quadruple therapy and underwent follow-up endoscopy with biopsy approximately six months later. Histological findings were compared with baseline findings.Results: H. pylori was not detected on follow-up histology in 64/70 patients (91.4%). Among patients with baseline lesions, gastric atrophy persisted in 9/13 (69.2%) and IM in 19/21 (90.5%). No new atrophy (0/57) or IM (0/49) was identified among patients without the corresponding baseline lesion.Conclusion: Gastric atrophy and IM remained detectable in most patients with these baseline lesions at six months. Longer follow-up is required to assess regression and treatment effects.Keywords
Funding Information
- No supporting instution.
This publication has 15 references indexed in Scilit:
- Long-term endoscopic gastric mucosal changes up to 20 years after Helicobacter pylori eradication therapyScientific Reports, 2024
- Long-Term Impact of Helicobacter pylori Eradication Therapy on Gastric Cancer Incidence and Mortality in Healthy Infected Individuals: A Meta-Analysis Beyond 10 Years of Follow-UpGastroenterology, 2022
- The Difference of Endoscopic and Histologic Improvements of Atrophic Gastritis and Intestinal Metaplasia After Helicobacter pylori EradicationDigestive Diseases and Sciences, 2021
- Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long‐term prospective follow‐up studyJournal of Gastroenterology and Hepatology, 2021
- AGA Clinical Practice Guidelines on Management of Gastric Intestinal MetaplasiaGastroenterology, 2019
- British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinomaGut, 2019
- Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication ‐ a prospective study for up to 10 yearsAlimentary Pharmacology & Therapeutics, 2017
- Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-AnalysisGastroenterology, 2017
- Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trialsBMJ, 2014
- Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: A long‐term prospective cohort studyJournal of Gastroenterology and Hepatology, 2010